CoF-DResNet: Cancer Metastasis Recognition Network based on Dynamic Coordinated Metabolic Attention and Structural Attention

IF 2.2 4区 医学 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY Current pharmaceutical biotechnology Pub Date : 2024-06-12 DOI:10.2174/0113892010302534240530073118
Sun Zhu, Huiyan Jiang, Zhaoshuo Diao, Qiu Luan, Yaming Li, Xuena Li, Yan Pei
{"title":"CoF-DResNet: Cancer Metastasis Recognition Network based on Dynamic\nCoordinated Metabolic Attention and Structural Attention","authors":"Sun Zhu, Huiyan Jiang, Zhaoshuo Diao, Qiu Luan, Yaming Li, Xuena Li, Yan Pei","doi":"10.2174/0113892010302534240530073118","DOIUrl":null,"url":null,"abstract":"\n\nCancer metastasis usually means that cancer cells spread to other tissues\nor organs, and the condition worsens. Identifying whether cancer has metastasized can help\ndoctors infer the progression of a patient's condition and is an essential prerequisite for devising\ntreatment plans. Fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography\n(18F -FDG PET/CT) is an advanced cancer diagnostic imaging technique that provides\nboth metabolic and structural information.\n\n\n\nIn cancer metastasis recognition tasks, effectively integrating metabolic and structural\ninformation stands as a key technology to enhance feature representation and recognition performance.\nThis paper proposes a cancer metastasis identification network based on dynamic\ncoordinated metabolic attention and structural attention to address these challenges. Specifically,\nmetabolic and structural features are extracted by incorporating a dynamic coordinated attention\nmodule (DCAM) into two branches of ResNet networks, thereby amalgamating high metabolic\nspatial information from PET images with texture structure information from CT images, and\ndynamically adjusting this process through iterations.\n\n\n\nNext, to improve the efficacy of feature expression, a multi-receptive field feature\nfusion module (MRFM) is included in order to execute multi-receptive field fusion of semantic\nfeatures.\n\n\n\nTo validate the effectiveness of our proposed model, experiments were conducted on\nboth a private lung lymph nodes dataset and a public soft tissue sarcomas dataset\n\n\n\nThe accuracy of our method reached 76.0% and 75.1% for the two datasets, respectively,\ndemonstrating an improvement of 6.8% and 5.6% compared to ResNet, thus affirming the\nefficacy of our method.\n","PeriodicalId":10881,"journal":{"name":"Current pharmaceutical biotechnology","volume":null,"pages":null},"PeriodicalIF":2.2000,"publicationDate":"2024-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current pharmaceutical biotechnology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/0113892010302534240530073118","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Cancer metastasis usually means that cancer cells spread to other tissues or organs, and the condition worsens. Identifying whether cancer has metastasized can help doctors infer the progression of a patient's condition and is an essential prerequisite for devising treatment plans. Fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography (18F -FDG PET/CT) is an advanced cancer diagnostic imaging technique that provides both metabolic and structural information. In cancer metastasis recognition tasks, effectively integrating metabolic and structural information stands as a key technology to enhance feature representation and recognition performance. This paper proposes a cancer metastasis identification network based on dynamic coordinated metabolic attention and structural attention to address these challenges. Specifically, metabolic and structural features are extracted by incorporating a dynamic coordinated attention module (DCAM) into two branches of ResNet networks, thereby amalgamating high metabolic spatial information from PET images with texture structure information from CT images, and dynamically adjusting this process through iterations. Next, to improve the efficacy of feature expression, a multi-receptive field feature fusion module (MRFM) is included in order to execute multi-receptive field fusion of semantic features. To validate the effectiveness of our proposed model, experiments were conducted on both a private lung lymph nodes dataset and a public soft tissue sarcomas dataset The accuracy of our method reached 76.0% and 75.1% for the two datasets, respectively, demonstrating an improvement of 6.8% and 5.6% compared to ResNet, thus affirming the efficacy of our method.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
CoF-DResNet:基于动态协调代谢注意力和结构注意力的癌症转移识别网络
癌症转移通常是指癌细胞扩散到其他组织或器官,导致病情恶化。确定癌症是否已经转移可以帮助医生推断患者病情的发展,是制定治疗方案的重要前提。在癌症转移识别任务中,有效整合代谢和结构信息是提高特征表示和识别性能的关键技术。本文提出了一种基于动态协调代谢关注和结构关注的癌症转移识别网络来应对这些挑战。具体来说,通过在 ResNet 网络的两个分支中加入动态协调注意力模块(DCAM)来提取代谢和结构特征,从而将 PET 图像中的高代谢空间信息与 CT 图像中的纹理结构信息融合在一起,并通过迭代对这一过程进行动态调整。为了验证我们提出的模型的有效性,我们在私人肺淋巴结数据集和公共软组织肉瘤数据集上进行了实验。在这两个数据集上,我们方法的准确率分别达到了 76.0% 和 75.1%,与 ResNet 相比分别提高了 6.8% 和 5.6%,从而肯定了我们方法的有效性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Current pharmaceutical biotechnology
Current pharmaceutical biotechnology 医学-生化与分子生物学
CiteScore
5.60
自引率
3.60%
发文量
203
审稿时长
6 months
期刊介绍: Current Pharmaceutical Biotechnology aims to cover all the latest and outstanding developments in Pharmaceutical Biotechnology. Each issue of the journal includes timely in-depth reviews, original research articles and letters written by leaders in the field, covering a range of current topics in scientific areas of Pharmaceutical Biotechnology. Invited and unsolicited review articles are welcome. The journal encourages contributions describing research at the interface of drug discovery and pharmacological applications, involving in vitro investigations and pre-clinical or clinical studies. Scientific areas within the scope of the journal include pharmaceutical chemistry, biochemistry and genetics, molecular and cellular biology, and polymer and materials sciences as they relate to pharmaceutical science and biotechnology. In addition, the journal also considers comprehensive studies and research advances pertaining food chemistry with pharmaceutical implication. Areas of interest include: DNA/protein engineering and processing Synthetic biotechnology Omics (genomics, proteomics, metabolomics and systems biology) Therapeutic biotechnology (gene therapy, peptide inhibitors, enzymes) Drug delivery and targeting Nanobiotechnology Molecular pharmaceutics and molecular pharmacology Analytical biotechnology (biosensing, advanced technology for detection of bioanalytes) Pharmacokinetics and pharmacodynamics Applied Microbiology Bioinformatics (computational biopharmaceutics and modeling) Environmental biotechnology Regenerative medicine (stem cells, tissue engineering and biomaterials) Translational immunology (cell therapies, antibody engineering, xenotransplantation) Industrial bioprocesses for drug production and development Biosafety Biotech ethics Special Issues devoted to crucial topics, providing the latest comprehensive information on cutting-edge areas of research and technological advances, are welcome. Current Pharmaceutical Biotechnology is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments.
期刊最新文献
Dihydroartemisinin Modulates Prostate Cancer Progression by Regulating Multiple Genes via the Transcription Factor NR2F2. Extraction, Isolation, Characterization, and Development of Phospholipids Complex Nanocarrier for Improved Solubility, Antiasthmatic, and Pharmacokinetic Potential of Curcuminoids. A Liquid Band-Aid with Mesenchymal Stem Cell-Derived Exosomes for Wound Healing in Mice. Ampullaviruses: From Extreme Environments to Biotechnological Innovation. Biomarkers and Novel Therapies of Diabetic Neuropathy: An Updated Review.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1